Login
Home / 7148.KL : KLS
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Duopharma Biotech Berhad

MYR 1.2 -$0.04 (-3.23%)
KLS · 14 Sep 2026 08:12 UTC
Previous Close
MYR 1.22
Day Range
MYR 1.18MYR 1.21
Year Range
MYR 1.18MYR 1.57
Market Cap
1.15B
AVG Volume
465.83K
Trailing/Forward PE
11.3/10.56
PEG ratio
3.26
Dividend Yield
3.79%
Next Earnings Date
2026-11-11
Primary Exchange
Malaysian Stock ExchangeMY
Revenue (MYR)
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (MYR)
010M20M30M40M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (MYR)
020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (MYR)
020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (MYR)
-20M020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (MYR)
00.010.020.030.0424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (MYR)
020M40M60M80MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (MYR)
0200M400M600MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
012324 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%20%40%60%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
0%2%4%6%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (MYR)
00.010.020.030.04Apr 22Aug 22Apr 23Sep 23Mar 24Aug 24Mar 25Sep 25Mar 26Sep 26
Book Value Per Share (MYR)
00.250.50.75124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (MYR)
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
1015202530med 17.22Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Free Cash Flow Yield
0%2%4%6%8%med 5.94%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
1.21.41.61.8med 1.43Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EV/EBITDA
68101214med 9.12Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price/Operating Cashflow
510152025med 11.67Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Book
1.41.61.82med 1.68Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Duopharma Biotech Berhad
7148.KL
Stockpicker

Video analysis: 7148.KL

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.